These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 8449285

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Insulin and GLUT2 glucose transporter immunoreactivity in B-cells of whole pancreas isografts and allografts in the streptozotocin-diabetic rat.
    Jörns A, Klempnauer J.
    Exp Clin Endocrinol Diabetes; 1995; 103 Suppl 2():103-6. PubMed ID: 8839264
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Are there kinetic advantages of GLUT2 in pancreatic glucose sensing?
    Sweet IR, Matschinsky FM.
    Diabetologia; 1997 Jan; 40(1):112-9. PubMed ID: 9028727
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Making sense of glucose sensing.
    Efrat S.
    Nat Genet; 1997 Nov; 17(3):249-50. PubMed ID: 9354775
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Alterations in net glucose uptake and in the pancreatic B-cell GLUT2 transporter induced by diazoxide and by secretory stimuli.
    Zhao L, Li Z, Kullin M, Borg LA, Karlsson FA.
    J Endocrinol; 2005 May; 185(2):291-9. PubMed ID: 15845921
    [Abstract] [Full Text] [Related]

  • 14. Glucose uptake, utilization, and signaling in GLUT2-null islets.
    Guillam MT, Dupraz P, Thorens B.
    Diabetes; 2000 Sep; 49(9):1485-91. PubMed ID: 10969832
    [Abstract] [Full Text] [Related]

  • 15. Gene therapy of diabetes: glucose-stimulated insulin secretion in a human hepatoma cell line (HEP G2ins/g).
    Simpson AM, Marshall GM, Tuch BE, Maxwell L, Szymanska B, Tu J, Beynon S, Swan MA, Camacho M.
    Gene Ther; 1997 Nov; 4(11):1202-15. PubMed ID: 9425444
    [Abstract] [Full Text] [Related]

  • 16. Regulated expression of GLUT2 in diabetes studied in transplanted pancreatic beta cells.
    Thorens B, Roduit R.
    Biochem Soc Trans; 1994 Aug; 22(3):684-7. PubMed ID: 7821664
    [Abstract] [Full Text] [Related]

  • 17. Overexpression of leptin receptors in pancreatic islets of Zucker diabetic fatty rats restores GLUT-2, glucokinase, and glucose-stimulated insulin secretion.
    Wang MY, Koyama K, Shimabukuro M, Mangelsdorf D, Newgard CB, Unger RH.
    Proc Natl Acad Sci U S A; 1998 Sep 29; 95(20):11921-6. PubMed ID: 9751766
    [Abstract] [Full Text] [Related]

  • 18. Diabetic hyperglycemia: link to impaired glucose transport in pancreatic beta cells.
    Unger RH.
    Science; 1991 Mar 08; 251(4998):1200-5. PubMed ID: 2006409
    [Abstract] [Full Text] [Related]

  • 19. Beta-cell GLUT-2 loss and non-insulin-dependent diabetes mellitus: current status of the hypothesis.
    Milburn JL, Ohneda M, Johnson JH, Unger RH.
    Diabetes Metab Rev; 1993 Oct 08; 9(3):231-6. PubMed ID: 8187609
    [No Abstract] [Full Text] [Related]

  • 20. Novel insulinoma cell lines produced by iterative engineering of GLUT2, glucokinase, and human insulin expression.
    Clark SA, Quaade C, Constandy H, Hansen P, Halban P, Ferber S, Newgard CB, Normington K.
    Diabetes; 1997 Jun 08; 46(6):958-67. PubMed ID: 9166666
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.